ags-v
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 15, 2017 (NCT03055000)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Anopheles gambiaeImmunity, active
Anopheles gambiae immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ags-v
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04009824 | Phase 1 | Jul 8, 2019 | National Institute of Allergy and Infectious Diseases (NIAID), SEEK, University of Maryland |
| NCT03055000 | Phase 1 | Feb 15, 2017 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 1 | 2017 |
| SEEK | For profit | 1 | 0 | 1 | 2019 |
| University of Maryland | Academic/Hospital | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1